Anixa Biosciences, Inc
Biotechnology - , California, United States
Anixa Biosciences, Inc Employees
Anixa Biosciences, Inc Senior Management
Anixa Biosciences, Inc Details
Anixa is a publicly-traded biotechnology company developing a number of programs addressing cancer and infectious disease. Anixa's therapeutic portfolio includes a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology, and a Covid-19 therapeutics program focused on inhibiting certain viral protein function. The company's vaccine portfolio consists of a technology focused on the immunization against α-Lactalbumin to prevent triple negative breast cancer (TNBC). Anixa continually examines emerging technologies in complementary fields for further development and commercialization.
Anixa Biosciences, Inc Technologies
Captcha
reCAPTCHA
Email Providers
Outlook
Load Balancers
Apache
Hosting
Amazon AWS
Analytics and Tracking
Google Analytics
Other
Mobile Friendly